Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled Phase 3 study of zonisamide in pediatric partial-onset epilepsy
2006-002515-27Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and Focal Onset Epilepsy comparing Zonisamide adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Responder rate during maintenance period. Started Sep 2007; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2006-002515-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002515-27.